CURE Pharmaceutical [OTCQB: CURR] Takes First Step To Secure Hemp CBD Supply Chain by Partnering with Fytiko Farms
21 août 2019 07h25 HE
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., Aug. 21, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it has signed a deal with Oklahoma-based hemp...
CURE Pharmaceutical Expands Board with Two Women Directors
07 août 2019 07h25 HE
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., Aug. 07, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced the addition of two directors to its Board,...
CURE Pharmaceutical [OTCQB:CURR] Secures Patent on High Loading of Active Ingredient in Oral Thin Films
24 juil. 2019 07h25 HE
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., July 24, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced the allowance of U.S. Application No....
CURE Pharmaceutical [OTCQB:CURR] and Canopy Growth to Produce CBD Oral Thin Films
19 juin 2019 07h25 HE
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif. , June 19, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it is collaborating with Canopy Growth...
CURE Pharmaceutical to Present at the 9th Annual LD Micro Invitational
30 mai 2019 07h25 HE
|
Cure Pharmaceutical Holding Corp.
LOS ANGELES, May 30, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that it will be presenting at the 9th Annual LD...
CURE Pharmaceutical Secures Patent on Oral Thin Film Containing Bioactive Cannabinoid Molecules
22 mai 2019 07h25 HE
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., May 22, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced the issuance of U.S. Patent No. 10,307,397,...
CURE Pharmaceutical Expands Leadership Team with Key New Hires
20 mai 2019 07h25 HE
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., May 20, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced the addition of four key hires to their growing...
CURE Pharmaceutical (OTCQB:CURR) Closes Acquisition Of Privately-Held Chemistry Holdings Inc.
14 mai 2019 09h25 HE
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., May 14, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR) (“CURE”), an innovative drug delivery and development company, today announced that it has closed on the previously...
Meroven LLC and CURE Pharmaceutical Enter Exclusive Marketing and Distribution Agreement for Spee-D for the USA
02 mai 2019 07h25 HE
|
Cure Pharmaceutical Holding Corp.
CHICAGO, May 02, 2019 (GLOBE NEWSWIRE) -- Today, at the CPhI Conference, Meroven LLC announced a five-year agreement with CURE Pharmaceutical Corporation (OTCQB: CURR) to exclusively market and...
CURE Pharmaceutical Extends Closing Of Privately-Held Chemistry Holdings Inc. Acquisition to May 13
01 mai 2019 07h25 HE
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., May 01, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR) (“CURE”), an innovative drug delivery and development company, today announced that it has extended the close of the...